{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_015080.3:c.2205A>G (p.I715M)",
          "cDNA Change": {
            "transcript": "NM_015080.3",
            "ref": "A",
            "alt": "G",
            "position": "2205"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "M",
            "position": "715"
          },
          "Description in input context": "Pathogenic mutations increase the tendency of dardarin to form inclusion bodies and cause cell death."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinsonâ€™s disease (PD)",
    "MONDO": "MONDO:0005547"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293 cells expressing mutant LRRK2",
        "Description": "The experiment was conducted using HEK293 cells expressing mutant LRRK2."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_015080.3:c.2205A>G (p.I715M)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Protein expression was reduced by 50% for the mutant LRRK2 variant NM_015080.3:c.2205A>G."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": ""
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": ""
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": ""
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression greater than 80%.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression less than 50%.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}